by 
Market Overview:
Blepharitis is a common eye condition characterized by inflammation of the eyelids. It causes burning, irritation and dryness of eyelids and base of eyelashes. The key symptoms include redness, flakiness or crusting of eyelids, itchy eyes, dry eyes and telangiectasia or small red blood vessels near eyelid margins. Blepharitis is commonly treated with warm compresses, lid scrubs and antibiotic ointments/drops.
The Blepharitis Treatment Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/blepharitis-treatment-market-1761
Market Dynamics:
Increasing incidence of eye related conditions such as blepharitis due to rising pollution levels and excessive screen time is a major factor driving the blepharitis treatment market growth. According to a study published in BMC Ophthalmology, blepharitis affects nearly 25% of the global population leading to significant economic burden. Moreover, advancements in medications and lid cleaning products along with awareness campaigns by eye care organizations are also fueling the market growth. However, alternative treatment methods such as herbal remedies can restrict market expansion to some extent over the forecast period.
Segment Analysis
In the global blepharitis treatment market, the antibiotic segment currently dominates due to high prevalence of antibiotic therapy for blepharitis treatment. Antibiotic treatment options are the first line of defense and are highly effective in controlling bacterial infection and related inflammation in mild to moderate cases of blepharitis.
PEST Analysis
Political: Regulations regarding use of antibiotics and steroid drops are expected to get more stringent over the forecast period to prevent overuse and misuse.
Economic: Rising geriatric population prone to chronic eye diseases and increasing healthcare spending is expected to drive growth of blepharitis treatment market.
Social: Growing awareness about eye care and availability of various treatment options is promoting patients to seek medical help for blepharitis symptoms rather than ignoring.
Technological: Advanced treatment options combining heat therapy, antibiotic, and expression techniques are becoming popular for effective blepharitis management with minimal side effects.
Key Takeaways
The global blepharitis treatment market is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing prevalence of blepharitis, growing geriatric population, and availability of advanced treatment options.
The North America blepharitis treatment market currently dominates the global market and is expected to continue its dominance over the forecast period due to high awareness levels, established healthcare infrastructure, and presence of major players. Europe blepharitis treatment market is anticipated to exhibit fastest growth rate owing to rising research initiatives and increasing healthcare spending.
Key players operating in the blepharitis treatment market are Scope Ophthalmic Ltd., NovaBay Pharmaceuticals Inc., Thea Pharmaceuticals Ltd., Perrigo Laboratories, InSite Vision Incorporated, Merck & Co., and Novartis AG. Major players are focusing on new product launches, and acquisitions to strengthen their market position.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
